✦ LIBER ✦

Immunotherapy of metastatic renal cell carcinoma

✍ Scribed by David F. McDermott

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 135 KB
Volume: 115
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.24236

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Surgical resection of metastatic renal c

Surgical resection of metastatic renal cell carcinoma and melanoma after response to interleukin-2-based immunotherapy

✍ Dr. Richard M. Shery; Harvey I. Pass; Steven A. Rosenberg; James C. Yang 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 473 KB 👁 2 views

Thirty-one patients with disseminated melanoma or renal cell cancer (RCC) who had a limited relapse or persistent disease after a partial or complete response to interleukin-2 (IL-z)-based immunotherapy underwent resection of progressing tumors or residual sites of disease. There were no surgery-rel

Granulocyte-macrophage–colony stimulatin

Granulocyte-macrophage–colony stimulating factor in combination immunotherapy for patients with metastatic renal cell carcinoma : Results of two Phase II clinical trials

✍ Christopher W. Ryan; Nicholas J. Vogelzang; Mary C. Dumas; Timothy Kuzel; Walter 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

The aim of this study was to determine the response rates and toxicity of two regimens containing granulocyte-macrophage-colony stimulating factor (GM-CSF) in combination with interleukin-2 (IL-2) in the treatment of patients with metastatic renal cell carcinoma. ## METHODS. Therapy given in the f

Sarcomatoid differentiation as a prognos

Sarcomatoid differentiation as a prognostic factor for immunotherapy in metastatic renal cell carcinoma

✍ Cheol Kwak; Yong Hyun Park; Chang Wook Jeong; Hyeon Jeong; Sang Eun Lee; Kyung C 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

Novel therapeutics for metastatic renal

Novel therapeutics for metastatic renal cell carcinoma

✍ Thomas E. Hutson; Robert A. Figlin 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

## Abstract The treatment of metastatic renal cell carcinoma (RCC) has changed dramatically during the past few years. Sunitinib malate, sorafenib tosylate, bevacizumab with interferon α, temsirolimus, and everolimus have improved clinical outcomes in randomized phase 3 trials by inhibiting the vas

Renal cell carcinoma metastatic to the t

Renal cell carcinoma metastatic to the thyroid

✍ Linda K. Green; Jae Y. Ro; Bruce Mackay; Alberto G. Ayala; Mario A. Luna 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 772 KB

Immunocompetence and spontaneous regress

Immunocompetence and spontaneous regression of metastatic renal cell carcinoma

✍ Dr. Peter D. Boasberg; Frederick R. Eilber; Dr. Donald L. Morton 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB

## Abstract Spontaneous remission of pulmonary metastases from renal cell carcinoma was correlated with a positive response to dinitrochlorobenzene (DNCB). When first seen, the patient was DNCB negative and a chest radiograph showed nodular densities in the right lung and left midlung. Six months a